Cerus (CERS) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 07/14/22
Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of DirectorsBusiness Wire • 07/05/22
Wall Street Analysts See an 89% Upside in Cerus (CERS): Can the Stock Really Move This High?Zacks Investment Research • 06/23/22
Does Cerus (CERS) Have the Potential to Rally 88% as Wall Street Analysts Expect?Zacks Investment Research • 06/03/22
Does Cerus (CERS) Have the Potential to Rally 89% as Wall Street Analysts Expect?Zacks Investment Research • 05/16/22
Cerus Corporation (CERS) CEO Obi Greenman on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/06/22
Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance RangeBusiness Wire • 05/05/22
Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System SetsBusiness Wire • 05/03/22
Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red CrossBusiness Wire • 04/25/22
Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022Business Wire • 04/21/22
Cerus Corporation to Participate at the Cowen 42nd Annual Health Care ConferenceBusiness Wire • 02/25/22
Does Cerus (CERS) Have the Potential to Rally 90% as Wall Street Analysts Expect?Zacks Investment Research • 02/23/22
Cerus Corporation (CERS) CEO Obi Greenman on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/23/22
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial ResultsBusiness Wire • 02/22/22
Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022Business Wire • 02/08/22
Cerus Corporation Announces Record Preliminary Fourth Quarter and Full-Year 2021 Product Revenue and Provides Business UpdateBusiness Wire • 01/10/22
How Much Upside is Left in Cerus (CERS)? Wall Street Analysts Think 44%Zacks Investment Research • 12/28/21
3 Beaten-Down Medical Product Stocks to Buy on a Turnaround in 2022Zacks Investment Research • 12/21/21
Wall Street Analysts Think Cerus (CERS) Could Surge 35%: Read This Before Placing a BetZacks Investment Research • 11/24/21